down arrow

Dizal (Jiangsu) Pharmaceutical Co., Ltd.

  • Market Cap: Large Cap
  • Industry: Miscellaneous
  • ISIN: CNE1000055W8
CNY
62.94
1.97 (3.23%)

Dec 05

SHG

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Dizal (Jiangsu) Pharmaceutical Co., Ltd.
Why is Dizal (Jiangsu) Pharmaceutical Co., Ltd. ?
1
Poor Management Efficiency with a low ROCE of 18.72%
  • The company has been able to generate a Return on Capital Employed (avg) of 18.72% signifying low profitability per unit of total capital (equity and debt)
2
High Debt Company with a Debt to Equity ratio (avg) at times
  • Poor long term growth as Net Sales has grown by an annual rate of 313.74% and Operating profit at -322.52% over the last 5 years
  • High Debt Company with a Debt to Equity ratio (avg) at times
  • The company has reported losses. Due to this company has reported negative ROE
3
Poor long term growth as Net Sales has grown by an annual rate of 313.74% and Operating profit at -322.52% over the last 5 years
4
Risky -
  • The stock is trading risky as compared to its average historical valuations
  • Over the past year, while the stock has generated a return of 29.92%, its profits have risen by 13.2%
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Miscellaneous)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Dizal (Jiangsu) Pharmaceutical Co., Ltd. for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
Dizal (Jiangsu) Pharmaceutical Co., Ltd.
35.06%
1.20
49.57%
China Shanghai Composite
15.19%
1.01
14.58%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
313.74%
EBIT Growth (5y)
-322.52%
EBIT to Interest (avg)
-7.00
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
27.08
Sales to Capital Employed (avg)
0.19
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
18.72%
ROE (avg)
0
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
17.72
EV to EBIT
-30.04
EV to EBITDA
-32.72
EV to Capital Employed
52.74
EV to Sales
54.36
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-175.56%
ROE (Latest)
-55.70%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bullish
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

18What is working for the Company
NET PROFIT(HY)

Higher at CNY -487.14 MM

RAW MATERIAL COST(Y)

Fallen by -30.27% (YoY

DEBTORS TURNOVER RATIO(HY)

Highest at 9.08%

NET SALES(Q)

Highest at CNY 159.26 MM

OPERATING PROFIT MARGIN(Q)

Highest at -134.63 %

PRE-TAX PROFIT(Q)

Highest at CNY -197.35 MM

-17What is not working for the Company
ROCE(HY)

Lowest at -227.74%

DEBT-EQUITY RATIO (HY)

Highest at 2,878.49 %

INVENTORY TURNOVER RATIO(HY)

Lowest at 2.03%

INTEREST(Q)

Highest at CNY 8.5 MM

Here's what is working for Dizal (Jiangsu) Pharmaceutical Co., Ltd.
Net Sales
At CNY 159.26 MM has Grown at 96.44%
Year on Year (YoY)
MOJO Watch
Near term sales trend is extremely positive

Net Sales (CNY MM)

Net Profit
Higher at CNY -487.14 MM
than preceding 12 month period ended Mar 2025
MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months

Net Profit (CNY MM)

Net Sales
Highest at CNY 159.26 MM
in the last five periods
MOJO Watch
Near term sales trend is positive

Net Sales (CNY MM)

Operating Profit Margin
Highest at -134.63 %
in the last five periods
MOJO Watch
Company's profit margin has improved

Operating Profit to Sales

Pre-Tax Profit
Highest at CNY -197.35 MM
in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (CNY MM)

Debtors Turnover Ratio
Highest at 9.08%
in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Raw Material Cost
Fallen by -30.27% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Dizal (Jiangsu) Pharmaceutical Co., Ltd.
Interest
At CNY 8.5 MM has Grown at 16.16%
period on period (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Debt-Equity Ratio
Highest at 2,878.49 % and Grown
In each half year in the last five Semi-Annual periods
MOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Inventory Turnover Ratio
Lowest at 2.03% and Fallen
In each half year in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling inventory has slowed

Inventory Turnover Ratio

Interest
Highest at CNY 8.5 MM
in the last five periods and Increased by 16.16% (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."